SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+19.42%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$1.87B
AUM Growth
+$1.87B
(-9.8%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-21.13%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
114
New
19
Increased
26
Reduced
20
Closed
11
Top Buys
| 1 |
Las Vegas Sands
LVS
|
$39.7M |
| 2 |
NVIDIA
NVDA
|
$32.8M |
| 3 |
Global Payments
GPN
|
$27.7M |
| 4 |
RH
RH
|
$27.4M |
| 5 |
TSMC
TSM
|
$23.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$73.2M |
| 2 |
Elevance Health
ELV
|
$67.7M |
| 3 |
Constellation Energy
CEG
|
$56.8M |
| 4 |
Estee Lauder
EL
|
$56.4M |
| 5 |
Colgate-Palmolive
CL
|
$54.4M |
Sector Composition
| 1 | Healthcare | 61.36% |
| 2 | Technology | 11.67% |
| 3 | Consumer Discretionary | 8.46% |
| 4 | Communication Services | 5.69% |
| 5 | Financials | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
InflaRx
IFRX
$108M
| $25.6M | 1.37% | 5,733,910 +3,587,670 | +167% | +$16M |
|
27
Ultragenyx Pharmaceutical
RARE
$2.89B
| $25M | 1.34% | 541,480 -75,000 | -12% | -$3.46M |
|
|
28
TSMC
TSM
$1.2T
| $23.9M | 1.28% | +237,031 | New | +$23.9M |
|
29
Zura Bio
ZURA
$133M
| $23.4M | 1.25% | +2,850,000 | New | +$23.4M |
|
30
Capital One
COF
$145B
| $21.7M | 1.16% | 198,570 -9,030 | -4% | -$988K |
|
31
Accenture
ACN
$162B
| $21.6M | 1.16% | +70,103 | New | +$21.6M |
|
32
GE Aerospace
GE
$292B
| $21.2M | 1.13% | +192,734 | New | +$21.2M |
|
33
Canadian Pacific Kansas City
CP
$69.9B
| $20.9M | 1.12% | 259,073 -239,737 | -48% | -$19.4M |
|
34
Goldman Sachs
GS
$226B
| $20.3M | 1.09% | 63,091 +5,456 | +9% | +$1.76M |
|
35
Fulcrum Therapeutics
FULC
$351M
| $18.9M | 1.01% | 5,718,881 +541,171 | +10% | +$1.79M |
|
|
DFS
36
DELISTED
Discover Financial Services
DFS
| $18.8M | 1.01% | +161,056 | New | +$18.8M |
|
37
KalVista Pharmaceuticals
KALV
$678M
| $18.3M | 0.98% | 2,034,506 +51,327 | +3% | +$462K |
|
38
Wells Fargo
WFC
$263B
| $18.1M | 0.97% | 423,506 +87,631 | +26% | +$3.74M |
|
39
Pinterest
PINS
$24.9B
| $18M | 0.96% | 658,390 -249,170 | -27% | -$6.81M |
|
40
Kezar Life Sciences
KZR
$28.9M
| $17.6M | 0.94% | 7,167,591 +280,000 | +4% | +$686K |
|
|
ATVI
41
DELISTED
Activision Blizzard Inc.
ATVI
| $17.5M | 0.93% | +207,188 | New | +$17.5M |
|
42
Hilton Worldwide
HLT
$64.9B
| $16.7M | 0.89% | 114,862 -307,232 | -73% | -$44.7M |
|
|
WWE
43
DELISTED
World Wrestling Entertainment
WWE
| $16.3M | 0.87% | +150,008 | New | +$16.3M |
|
44
Celsius Holdings
CELH
$16.2B
| $14.4M | 0.77% | +96,215 | New | +$14.4M |
|
45
Johnson & Johnson
JNJ
$427B
| $13.7M | 0.73% | 82,800 +27,510 | +50% | +$4.55M |
|
46
Marvell Technology
MRVL
$54.2B
| $13.6M | 0.73% | 226,873 -62,427 | -22% | -$3.73M |
|
47
Agios Pharmaceuticals
AGIO
$2.19B
| $12.9M | 0.69% | 454,000 | – | – |
|
48
Sana Biotechnology
SANA
$777M
| $12.6M | 0.67% | 2,113,800 | – | – |
|
49
Union Pacific
UNP
$133B
| $12.5M | 0.67% | 61,152 -180,429 | -75% | -$36.9M |
|
|
RETA
50
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $11.1M | 0.59% | 108,832 +93,732 | +621% | +$9.56M |
|